1. Home
  2. LNSR vs BNR Comparison

LNSR vs BNR Comparison

Compare LNSR & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNSR
  • BNR
  • Stock Information
  • Founded
  • LNSR 2004
  • BNR 2014
  • Country
  • LNSR United States
  • BNR China
  • Employees
  • LNSR N/A
  • BNR N/A
  • Industry
  • LNSR Medical Electronics
  • BNR Medical Specialities
  • Sector
  • LNSR Health Care
  • BNR Health Care
  • Exchange
  • LNSR Nasdaq
  • BNR Nasdaq
  • Market Cap
  • LNSR 63.4M
  • BNR 72.4M
  • IPO Year
  • LNSR N/A
  • BNR 2020
  • Fundamental
  • Price
  • LNSR $8.32
  • BNR $6.53
  • Analyst Decision
  • LNSR
  • BNR
  • Analyst Count
  • LNSR 0
  • BNR 0
  • Target Price
  • LNSR N/A
  • BNR N/A
  • AVG Volume (30 Days)
  • LNSR 52.9K
  • BNR 28.7K
  • Earning Date
  • LNSR 03-03-2025
  • BNR 12-03-2024
  • Dividend Yield
  • LNSR N/A
  • BNR N/A
  • EPS Growth
  • LNSR N/A
  • BNR N/A
  • EPS
  • LNSR N/A
  • BNR N/A
  • Revenue
  • LNSR $48,868,000.00
  • BNR $72,832,704.00
  • Revenue This Year
  • LNSR $25.07
  • BNR $52.90
  • Revenue Next Year
  • LNSR $24.95
  • BNR $48.35
  • P/E Ratio
  • LNSR N/A
  • BNR N/A
  • Revenue Growth
  • LNSR 21.29
  • BNR N/A
  • 52 Week Low
  • LNSR $2.67
  • BNR $2.62
  • 52 Week High
  • LNSR $9.23
  • BNR $9.80
  • Technical
  • Relative Strength Index (RSI)
  • LNSR 53.60
  • BNR 49.85
  • Support Level
  • LNSR $7.25
  • BNR $6.50
  • Resistance Level
  • LNSR $9.13
  • BNR $7.39
  • Average True Range (ATR)
  • LNSR 0.63
  • BNR 0.35
  • MACD
  • LNSR -0.07
  • BNR -0.14
  • Stochastic Oscillator
  • LNSR 56.61
  • BNR 25.41

About LNSR LENSAR Inc.

LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: